Can’t see the audio player? Click here to listen. About This Podcast Health care — and how much it costs — is scary. But you’re not alone with this stuff, and knowledge is power. “An Arm and a Leg” is a podcast about these issues, and its second season is co-produced by KHN. Visit armandalegshow.com Anna […]
Can’t see the audio player? Click here to listen on SoundCloud. Julie Rovner Kaiser Health News @jrovner Read Julie’s Stories Jennifer Haberkorn Los Angeles Times @jenhab Read Jennifer’s Stories Joanne Kenen Politico @JoanneKenen Read Joanne’s Stories Alice Miranda Ollstein Politico @AliceOllstein Read Alice’s Stories Congress is approving still more money to address the health and economic
Lab personnel say worries are mounting over the safety of a rapid coronavirus test by Abbott Laboratories that President Donald Trump has repeatedly lauded ― particularly, the risk of infection to those handling it. Trump and federal health officials have promoted the ease with which the Abbott test can be given to patients, whether at
Opioid addiction isn’t taking a break during the coronavirus pandemic. But the U.S. response to the viral crisis is making addiction treatment easier to get. Under the national emergency declared by the Trump administration in March, the government has suspended a federal law that required patients to have an in-person visit with a physician before
“Until this week, they [OSHA] weren’t even enforcing these guidelines. Still today, OSHA is not specifying which rules employees must follow or how to keep their workers safe and healthy.” Former Vice President Joe Biden in comments made during an April 15 virtual town hall meeting. This story was produced in partnership with PolitiFact. This
It started with a headache in late March. Then came the body aches. At first, Shalondra Rollins’ doctor thought it was the flu. By April 7, three days after she was finally diagnosed with COVID-19, the 38-year-old teaching assistant told her mom she was feeling winded. Within an hour, she was in an ambulance, conscious
In the throes of the novel coronavirus outbreak in early April, Kenneth Raske, president of the powerful Greater New York Hospital Association, took his case for needing billions in federal relief funding to another New Yorker, well placed in the White House. The April 8 call with Jared Kushner lasted “probably 30 seconds.” After all,
Patients who get financial help from drug companies to cover their copayments for prescription drugs could owe a bigger chunk of their costs under a proposed federal rule. The annual rule, which sets a wide range of standards regarding benefits and payments for most health plans for next year, would allow employers and insurers to
Can’t see the audio player? Click here to listen on SoundCloud. Julie Rovner Kaiser Health News @jrovner Read Julie’s Stories Anna Edney Bloomberg @annaedney Read Anna’s Stories Kimberly Leonard Business Insider @leonardkl Read Kimberly’s Stories Tami Luhby CNN @luhby Read Tami’s Stories President Donald Trump wants to reopen the country soon. But public health experts from
A growing mix of health and technology experts are convinced that if the United States is to ever effectively track the coronavirus and slow its spread, then both self-reported and more surreptitiously gathered personal data — a mix of information about location, travel, symptoms and health conditions ― must be gathered from millions of Americans.
Each week, KHN compiles a selection of recently released health policy studies and briefs.
At about 5 a.m. on March 19, a New York City ER physician named Frank Gabrin texted a friend about his concerns over the lack of medical supplies at hospitals. “It’s busy ― everyone wants a COVID test that I do not have to give them,” he wrote in the message to Eddy Soffer. “So
